Prepare a Fundraise

Build a credible fundraising process from verified company context, approved financial information, real market evidence, and supported investor fit.

The objective is not to make the company appear stronger than the evidence allows. The objective is to help the founder present the strongest defensible case, identify gaps, target appropriate investors, and move the process forward deliberately.

1. Define the raise

Establish:

• fundraising stage;
• target amount;
• intended use of funds;
• current runway;
• desired runway after the raise where relevant;
• timing;
• intended financing outcome;
• decision or milestone the capital should unlock;
• immediate audience;
• deadline;
• current fundraising status.

Clarify the first useful output.

This may be:

• fundraising brief;
• narrative review;
• evidence-gap review;
• first investor set;
• investor pipeline structure;
• fundraising deck;
• financial appendix;
• diligence plan;
• data-room checklist;
• near-term fundraising process.

Use the founder's established fundraising process when one exists.

Otherwise create the smallest practical approach covering:

• story;
• evidence gaps;
• investor profile;
• required research;
• first artifact;
• review point.

Resolve ambiguity that could materially change the fundraising strategy before launching substantial research or producing polished materials.

Do not turn preparation into an unnecessary setup exercise.

2. Build the evidence foundation

Use permitted company context available through relevant sources such as:

• current investor or board deck;
• financial model;
• operating dashboards;
• cap table;
• previous fundraising material;
• prior investor conversations;
• investor pipeline;
• customer evidence;
• product evidence;
• market research;
• team information;
• company metrics;
• approved diligence files;
• data room.

These are potential sources, not mandatory prerequisites.

For important financial, ownership, or cap-table figures, reconcile against the accepted authoritative source.

Treat model-generated or inferred figures as working outputs until reviewed by the founder or responsible owner.

For every material fundraising claim:

• preserve the source;
• preserve the relevant date;
• distinguish fact from inference;
• distinguish internal metrics from external benchmarks;
• identify stale evidence;
• identify contradictory evidence;
• expose missing evidence;
• mark low-confidence conclusions.

Never manufacture:

• traction;
• revenue;
• growth;
• customer evidence;
• market size;
• partnerships;
• investor interest;
• team credentials;
• product readiness;
• financial projections.

When the founder's preferred writing style matters and a trusted style profile exists, use it. Otherwise keep the voice concise, specific, and evidence-led.

3. Shape the fundraising story

Build a concise narrative around:

• problem;
• why now;
• product;
• market;
• traction;
• advantage;
• team;
• execution plan;
• fundraising ask.

Pressure-test the narrative using the questions investors typically underwrite:

• Is the market large or important enough?
• Why is this team credible?
• What evidence shows demand?
• What makes the product or company difficult to replace?
• What is the economic model?
• Can the team execute?
• What are the major risks?
• What will the new capital change?

Surface evidence that conflicts with the preferred story.

Do not hide weak or contradictory evidence behind stronger wording or visual polish.

Separate:

• verified claims;
• founder interpretation;
• projections;
• hypotheses;
• unresolved questions.

4. Create only the materials required for the current stage

Produce the smallest set of artifacts needed for the accepted fundraising step.

Possible materials include:

• fundraising brief;
• investor deck;
• financial appendix;
• investor FAQ;
• diligence-answer pack;
• data-room checklist;
• investor tracker;
• pipeline tracker;
• evidence-gap register.

When approved content needs to become a presentation, route production through the environment's presentation workflow rather than duplicating specialized deck-production logic.

Source diligence answers wherever possible.

Keep unresolved diligence questions visible instead of inventing confident responses.

Separate:

• internal working material;
• founder-only information;
• investor-ready material;
• confidential diligence material.

Keep confidential files in approved locations.

5. Define the target investor profile

Build the investor profile from the actual raise.

Consider:

• stage;
• check size;
• geography;
• sector thesis;
• business model;
• company maturity;
• portfolio relevance;
• relevant operating experience;
• ownership expectations;
• lead/follow behavior;
• known exclusions.

Use ecosystem or market-mapping research when the investor landscape itself must be understood before list building.

Do not begin with a generic list of famous funds.

6. Build and calibrate the investor set

Treat investment firms and individual partners as separate entities when that distinction affects fit or outreach.

Deduplicate against:

• approved CRM or pipeline records;
• previous conversations;
• existing relationships;
• prior outreach.

For each candidate, preserve:

• firm;
• relevant partner where supported;
• current source;
• source date;
• stage fit;
• check-size fit;
• thesis fit;
• relevant portfolio or experience;
• evidence-backed fit reason;
• possible introduction path only when verified.

Never imply:

• a warm relationship;
• investor interest;
• partner familiarity;
• introduction availability;
• prior contact

without supporting evidence.

Review a small, varied sample before expanding the list.

Around ten investors may be sufficient for initial calibration, but the correct sample size depends on the raise and available evidence.

Report:

• strong matches;
• borderline matches;
• exclusions;
• stale evidence;
• contradictions;
• coverage gaps.

Do not pad the investor list simply to reach a numerical target.

7. Review with the founder before scaling

Review together:

• fundraising story;
• first investor set;
• important evidence gaps;
• one representative fundraising artifact.

Carry corrections into the remaining research and materials.

Use the review to calibrate:

• investor fit;
• tone;
• claims;
• evidence standards;
• exclusions;
• level of detail.

Do not scale a flawed investor profile or narrative.

8. Turn preparation into a practical process

Build a near-term fundraising plan containing:

• owners;
• next actions;
• dependencies;
• deadlines;
• review points;
• materials required;
• investor research status;
• communication status.

Use a two-week horizon when it matches the founder's process, but do not treat it as mandatory.

When an approved investor list should become outreach, route that work through the appropriate outbound or personalized outreach workflow.

Keep:

• investor research;
• contact verification;
• drafting;
• approval;
• sending

inside the rules of that workflow.

For scheduled investor conversations, use the environment's meeting-preparation workflow and preserve decisions, questions, and commitments after a reliable meeting record exists.

9. Maintain fundraising action boundaries

Treat these as separate actions:

• researching investors;
• drafting fundraising material;
• changing investor pipeline records;
• contacting investors;
• sending fundraising material;
• sharing confidential files;
• granting data-room access;
• changing access permissions;
• making commercial or financial commitments.

Follow active scoped permissions for every:

• company system;
• investor source;
• account;
• destination;
• action.

Stop or request review when:

• investor identity is ambiguous;
• company identity or scope changes;
• sensitive financial data handling changes;
• confidential information may be exposed;
• source authority changes;
• requested action exceeds permission.

Verify completed external actions when possible.

10. Preserve the accepted fundraising method

After the process proves useful, preserve reusable elements such as:

• story structure;
• evidence standards;
• investor criteria;
• source preferences;
• exclusions;
• artifact choices;
• diligence rules;
• review checkpoints.

Remove confidential or raise-specific information before converting the method into reusable team guidance.

Only add recurring automation when there is:

• a real trigger or cadence;
• stable source systems;
• clearly defined outputs;
• explicit review behavior;
• clear approval boundaries;
• stop conditions.

Recurring fundraising automation should prepare reviewable work rather than making investor commitments or sending external material without explicit authorization.